Search

John C. Fox

Examiner (ID: 3915)

Most Active Art Unit
3753
Art Unit(s)
3407, 3753, 2899, 2602, 3727
Total Applications
3766
Issued Applications
2890
Pending Applications
143
Abandoned Applications
734

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 18434313 [patent_doc_number] => 20230181607 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-06-15 [patent_title] => THIOSACCHARIDES FOR USE IN TREATING CORONAVIRUS INFECTION [patent_app_type] => utility [patent_app_number] => 17/924662 [patent_app_country] => US [patent_app_date] => 2021-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 87495 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -82 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17924662 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/924662
Thiosaccharides for use in treating coronavirus infection May 10, 2021 Issued
Array ( [id] => 17168789 [patent_doc_number] => 20210322459 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-10-21 [patent_title] => PROPHYLACTIC USE OF INULIN AGAINST SINUSITIS [patent_app_type] => utility [patent_app_number] => 17/315436 [patent_app_country] => US [patent_app_date] => 2021-05-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4770 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => 0 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17315436 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/315436
Prophylactic use of inulin against sinusitis May 9, 2021 Issued
Array ( [id] => 17050652 [patent_doc_number] => 20210260086 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-08-26 [patent_title] => METHODS OF INHIBITION OF PROTEIN FUCOSYLATION IN VIVO USING FUCOSE ANALOGS [patent_app_type] => utility [patent_app_number] => 17/315144 [patent_app_country] => US [patent_app_date] => 2021-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19611 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -4 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17315144 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/315144
METHODS OF INHIBITION OF PROTEIN FUCOSYLATION IN VIVO USING FUCOSE ANALOGS May 6, 2021 Abandoned
Array ( [id] => 18420220 [patent_doc_number] => 20230174681 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-06-08 [patent_title] => PARAMYLON-BASED RESIN, MOLDING MATERIAL, MOLDED BODY, AND PRODUCTION METHOD FOR PARAMYLON-BASED RESIN [patent_app_type] => utility [patent_app_number] => 17/923787 [patent_app_country] => US [patent_app_date] => 2021-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16780 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 132 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17923787 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/923787
Paramylon-based resin, molding material, molded body, and production method for paramylon-based resin May 6, 2021 Issued
Array ( [id] => 18405798 [patent_doc_number] => 20230167149 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-06-01 [patent_title] => CD33 LIGANDS SUITABLE FOR INCORPORATION INTO CARRIERS [patent_app_type] => utility [patent_app_number] => 17/997374 [patent_app_country] => US [patent_app_date] => 2021-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22622 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -49 [patent_words_short_claim] => 538 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17997374 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/997374
CD33 LIGANDS SUITABLE FOR INCORPORATION INTO CARRIERS Apr 29, 2021 Abandoned
Array ( [id] => 18525467 [patent_doc_number] => 11712445 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-08-01 [patent_title] => Compositions and methods for improving gastrointestinal function in subjects with renal disease [patent_app_type] => utility [patent_app_number] => 17/246433 [patent_app_country] => US [patent_app_date] => 2021-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3204 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17246433 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/246433
Compositions and methods for improving gastrointestinal function in subjects with renal disease Apr 29, 2021 Issued
Array ( [id] => 18466894 [patent_doc_number] => 20230201174 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-06-29 [patent_title] => COMBINATION OF FINERENONE AND A SGLT2 INHIBITOR FOR THE TREATMENT AND/OR PREVENTION OF CARDIOVASCULAR AND/OR RENAL DISEASES [patent_app_type] => utility [patent_app_number] => 17/996816 [patent_app_country] => US [patent_app_date] => 2021-04-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 40998 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17996816 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/996816
COMBINATION OF FINERENONE AND A SGLT2 INHIBITOR FOR THE TREATMENT AND/OR PREVENTION OF CARDIOVASCULAR AND/OR RENAL DISEASES Apr 19, 2021 Pending
Array ( [id] => 18451628 [patent_doc_number] => 20230192907 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-06-22 [patent_title] => PROCESS FOR THE PREPARATION OF LOW MOLECULAR WEIGHT LINEAR HYALURONIC ACID AND HYALURONIC ACID SO OBTAINED [patent_app_type] => utility [patent_app_number] => 17/918659 [patent_app_country] => US [patent_app_date] => 2021-04-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4885 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17918659 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/918659
PROCESS FOR THE PREPARATION OF LOW MOLECULAR WEIGHT LINEAR HYALURONIC ACID AND HYALURONIC ACID SO OBTAINED Apr 15, 2021 Pending
Array ( [id] => 17020987 [patent_doc_number] => 20210244858 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-08-12 [patent_title] => SOFT TISSUE FILLER COMPOSITION WITH HYALURONIC ACID AND BENZYL ALCOHOL [patent_app_type] => utility [patent_app_number] => 17/227714 [patent_app_country] => US [patent_app_date] => 2021-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1879 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -1 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17227714 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/227714
SOFT TISSUE FILLER COMPOSITION WITH HYALURONIC ACID AND BENZYL ALCOHOL Apr 11, 2021 Abandoned
Array ( [id] => 20264108 [patent_doc_number] => 12435084 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-10-07 [patent_title] => Indazole derivatives as inhibitors of SARM1 [patent_app_type] => utility [patent_app_number] => 17/995046 [patent_app_country] => US [patent_app_date] => 2021-04-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 25503 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 121 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17995046 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/995046
Indazole derivatives as inhibitors of SARM1 Apr 6, 2021 Issued
Array ( [id] => 18374353 [patent_doc_number] => 20230149432 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-05-18 [patent_title] => Human Milk Oligosaccharides for Improving Resistance of Organism Against Staphylococcus Aureus Infection [patent_app_type] => utility [patent_app_number] => 17/995228 [patent_app_country] => US [patent_app_date] => 2021-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8553 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17995228 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/995228
Human Milk Oligosaccharides for Improving Resistance of Organism Against Staphylococcus Aureus Infection Apr 5, 2021 Pending
Array ( [id] => 18948130 [patent_doc_number] => 11891411 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-02-06 [patent_title] => Industrial utilization method for [patent_app_type] => utility [patent_app_number] => 17/216928 [patent_app_country] => US [patent_app_date] => 2021-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5753 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 142 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17216928 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/216928
Industrial utilization method for Mar 29, 2021 Issued
Array ( [id] => 18626644 [patent_doc_number] => 20230285442 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-09-14 [patent_title] => USE OF OLIGOCHITOSANS AND DERIVATIVES THEREOF FOR NEUTRALIZING VIRAL AGENTS [patent_app_type] => utility [patent_app_number] => 17/914225 [patent_app_country] => US [patent_app_date] => 2021-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26433 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17914225 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/914225
USE OF OLIGOCHITOSANS AND DERIVATIVES THEREOF FOR NEUTRALIZING VIRAL AGENTS Mar 25, 2021 Pending
Array ( [id] => 19246788 [patent_doc_number] => 20240197772 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-06-20 [patent_title] => COMPOSITIONS COMPRISING ONE OR MORE HMO'S WITH A CORE OF LacNAc-Lac [patent_app_type] => utility [patent_app_number] => 17/909854 [patent_app_country] => US [patent_app_date] => 2021-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9168 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 115 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17909854 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/909854
COMPOSITIONS COMPRISING ONE OR MORE HMO'S WITH A CORE OF LacNAc-Lac Mar 23, 2021 Pending
Array ( [id] => 18312639 [patent_doc_number] => 20230116539 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-04-13 [patent_title] => Collagenase Activity Inhibitor [patent_app_type] => utility [patent_app_number] => 17/913874 [patent_app_country] => US [patent_app_date] => 2021-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7277 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -4 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17913874 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/913874
Collagenase Activity Inhibitor Mar 21, 2021 Pending
Array ( [id] => 18359381 [patent_doc_number] => 20230140972 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-05-11 [patent_title] => GLYCEROL GLUCOSIDE-BASED COMPOUND AND COMPOSITION COMPRISING SAME FOR ULTRAVIOLET LIGHT SHIELD OR ANTI-INFLAMMATION [patent_app_type] => utility [patent_app_number] => 17/912340 [patent_app_country] => US [patent_app_date] => 2021-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9593 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17912340 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/912340
GLYCEROL GLUCOSIDE-BASED COMPOUND AND COMPOSITION COMPRISING SAME FOR ULTRAVIOLET LIGHT SHIELD OR ANTI-INFLAMMATION Mar 18, 2021 Abandoned
Array ( [id] => 18338185 [patent_doc_number] => 20230130134 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-04-27 [patent_title] => METHOD OF TREATING VIRAL INFECTIONS WITH HEXOSE TYPE MONOSACCHARIDES AND ANALOGS THEREOF [patent_app_type] => utility [patent_app_number] => 17/906459 [patent_app_country] => US [patent_app_date] => 2021-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11251 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17906459 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/906459
METHOD OF TREATING VIRAL INFECTIONS WITH HEXOSE TYPE MONOSACCHARIDES AND ANALOGS THEREOF Mar 15, 2021 Pending
Array ( [id] => 17095369 [patent_doc_number] => 20210283160 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-09-16 [patent_title] => VIRAL INHIBITION [patent_app_type] => utility [patent_app_number] => 17/201621 [patent_app_country] => US [patent_app_date] => 2021-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9849 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -26 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17201621 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/201621
Viral inhibition Mar 14, 2021 Issued
Array ( [id] => 19622825 [patent_doc_number] => 12161616 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-12-10 [patent_title] => Combination therapy comprising an omega-3 fatty acid, a folate species and a vitamin B12 species [patent_app_type] => utility [patent_app_number] => 17/194517 [patent_app_country] => US [patent_app_date] => 2021-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 4 [patent_no_of_words] => 14931 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 157 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17194517 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/194517
Combination therapy comprising an omega-3 fatty acid, a folate species and a vitamin B12 species Mar 7, 2021 Issued
Array ( [id] => 18287127 [patent_doc_number] => 20230102599 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-03-30 [patent_title] => HIGHLY RESISTANT STARCH AND MANUFACTURING PROCESS THEREFOR [patent_app_type] => utility [patent_app_number] => 17/904933 [patent_app_country] => US [patent_app_date] => 2021-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5203 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17904933 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/904933
HIGHLY RESISTANT STARCH AND MANUFACTURING PROCESS THEREFOR Feb 25, 2021 Pending
Menu